Page last updated: 2024-10-26

valproic acid and Mitochondrial Myopathies

valproic acid has been researched along with Mitochondrial Myopathies in 4 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Mitochondrial Myopathies: A group of muscle diseases associated with abnormal mitochondria function.

Research Excerpts

ExcerptRelevanceReference
"He developed coma and acute liver failure that were attributed to VPA toxicity, and underwent emergency orthotopic liver transplantation (OLTx)."1.31Inappropriate liver transplantation in a child with Alpers-Huttenlocher syndrome misdiagnosed as valproate-induced acute liver failure. ( Camboulives, J; Delarue, A; Guys, JM; Lethel, V; Montfort, MF; Paut, O; Pellissier, JF; Roquelaure, B; Sarles, J, 2000)
"The brother has suffered from CPEO since early childhood but has had so far no other symptoms of a mitochondrial disease."1.31Mitochondrial diseases represent a risk factor for valproate-induced fulminant liver failure. ( Brandner, S; Kleinle, S; Krähenbühl, S; Liechti, S; Straumann, D, 2000)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hadzić, N1
Vara, R1
Raiman, J1
Mieli-Vergani, G1
Delarue, A1
Paut, O1
Guys, JM1
Montfort, MF1
Lethel, V1
Roquelaure, B1
Pellissier, JF1
Sarles, J1
Camboulives, J1
Kelly, DA1
Krähenbühl, S1
Brandner, S1
Kleinle, S1
Liechti, S1
Straumann, D1

Other Studies

4 other studies available for valproic acid and Mitochondrial Myopathies

ArticleYear
Old versus new antiepileptic drugs: the SANAD study.
    Lancet (London, England), 2007, Jul-28, Volume: 370, Issue:9584

    Topics: Adolescent; Anticonvulsants; Diagnostic Errors; Female; Humans; Kearns-Sayre Syndrome; Liver Failure

2007
Inappropriate liver transplantation in a child with Alpers-Huttenlocher syndrome misdiagnosed as valproate-induced acute liver failure.
    Pediatric transplantation, 2000, Volume: 4, Issue:1

    Topics: Anticonvulsants; Brain; Child, Preschool; Diagnosis, Differential; Diagnostic Errors; Diffuse Cerebr

2000
Liver transplantation: to do or not to do?
    Pediatric transplantation, 2000, Volume: 4, Issue:3

    Topics: Anticonvulsants; Child; Contraindications; Diffuse Cerebral Sclerosis of Schilder; Epilepsy; Female;

2000
Mitochondrial diseases represent a risk factor for valproate-induced fulminant liver failure.
    Liver, 2000, Volume: 20, Issue:4

    Topics: Adult; Anticonvulsants; Contraindications; DNA, Mitochondrial; Fatal Outcome; Female; Humans; Liver

2000